Clinical characteristics, disease flares, infections and their impact on kidney outcomes in pediatric lupus nephritis: A cohort study

被引:0
|
作者
Lama, Madhurima Veronica [1 ]
Deepthi, Bobbity [1 ]
Krishnasamy, Sudarsan [1 ]
Ganesh, Rajesh Nachiappa [2 ]
Srinivas, Bheemanathi Hanuman [2 ]
Rajappa, Medha [3 ]
Krishnamurthy, Sriram [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Pediat, Pediat Nephrol Serv, Pondicherry 605006, India
[2] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Pathol, Pondicherry 605006, India
[3] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Biochem, Pondicherry 605006, India
关键词
Lupus nephritis; Severe infections; Kidney flares; Complete response; Major adverse kidney events; SINGLE-CENTER EXPERIENCE; CHILDHOOD-ONSET LUPUS; CHILDREN; ERYTHEMATOSUS; CLASSIFICATION; ADOLESCENTS; RITUXIMAB; EFFICACY; SAFETY; NORTH;
D O I
10.1007/s00467-025-06666-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Limited data exists on clinical predictors of kidney outcomes in children with lupus nephritis (LN). Methods Children aged below 18 years with biopsy-proven LN followed from January 2010 to February 2024 in a tertiary-care center were enrolled in order to characterize their clinical presentations, flares, infections, histology and determine Major Adverse Kidney Events (MAKE) (defined as eGFR < 60 mL/min/1.73 m2 and/or death). Data was analysed to identify predictive factors of adverse outcomes. Results Seventy-five children (20% boys) with median (IQR) age at diagnosis 11.2 (9,13) years, were studied. Clinical presentations were nephritic syndrome, mixed nephritic-nephrotic features, rapidly progressive glomerulonephritis (RPGN), and nephrotic syndrome in 24 (32%), 15 (20%), 11 (14.7%) and 5 (6.7%) patients, respectively. Proliferative LN was the major (70.6%) histological subtype. In total, 75 kidney flares (21.3% nephritic) with incidence rate (IR) of 0.48 flares per person-year were noted in 31 (41.3%) children. Infections occurred in 32 (42.6%), with IR of 0.58 episodes per person-year. Bacterial pneumonia 14 (22.9%), sepsis 10 (16.3%) and tropical infections 6 (9.8%) were most common. At median last follow-up of 2.3 (1.3, 5.6) years with 85.4% kidney-survival rate, 41 (54.6%), and 21 (28%) were in complete-response (CR), and partial-response (PR), respectively. Proliferative LN and those in PR or NR were at significantly higher risk of kidney flares and infections, regardless of initial induction therapy. RPGN at presentation, non-responders at 6 months and severe kidney flare ever predicted MAKE in 11 (14.6%) children. Conclusions Multiple kidney flares and infections constitute a significant morbidity in LN. RPGN, non-responders and severe kidney flare predict adverse kidney outcomes.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus
    Buyon, Jill P.
    Kim, Mimi Y.
    Guerra, Marta M.
    Lu, Sifan
    Reeves, Emily
    Petri, Michelle
    Laskin, Carl A.
    Lockshin, Michael D.
    Sammaritano, Lisa R.
    Branch, D. Ware
    Porter, T. Flint
    Sawitzke, Allen
    Merrill, Joan T.
    Stephenson, Mary D.
    Cohn, Elisabeth
    Salmon, Jane E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (06): : 940 - 946
  • [32] Insights into pediatric lupus nephritis: clinical features and short-term outcomes from a single center retrospective study
    Sabeeta Khatri
    Irshad Ali Bajeer
    Madiha Aziz
    Mohammed Mubarak
    Ali Asghar Lanewala
    Seema Hashmi
    BMC Nephrology, 26 (1)
  • [33] Clinicopathologic Characteristics and Outcomes of Lupus Nephritis With Antineutrophil Cytoplasmic Antibody A Retrospective Study
    Wang, Yuan
    Huang, Xin
    Cai, Juan
    Xie, Lijiao
    Wang, Weili
    Tang, Sha
    Yin, Shiwei
    Gao, Xuejing
    Zhang, Jun
    Zhao, Jinghong
    Huang, Yunjian
    Li, Yafei
    Zhang, Ying
    Zhang, Jingbo
    MEDICINE, 2016, 95 (04)
  • [34] Exposure-response relationship of mycophenolic acid in pediatric lupus nephritis patients receiving multi-target therapy: An observational cohort study
    Chen, Lizhi
    Zhang, Lu
    Liu, Baojing
    Liu, Xiaohong
    Huang, Zhijun
    Tang, Kejing
    Chen, Pan
    Jiang, Xiaoyun
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 72
  • [35] Clinical characteristics and prevalence of complications of chronic kidney disease in children: the Taiwan Pediatric Renal Collaborative study
    Chou, Hsin-Hsu
    Lin, Ching-Yuang
    Chiou, Yee-Hsuan
    Tain, You-Lin
    Wang, Yi-Fan
    Wang, Hsin-Hui
    Chiou, Yuan-Yow
    PEDIATRIC NEPHROLOGY, 2016, 31 (07) : 1113 - 1120
  • [36] Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study
    Torres-Ruiz, J.
    Barrera-Vargas, A.
    Ortiz-Hernandez, R.
    Alcocer-Varela, J.
    Ponce-de-Leon, A.
    Gomez-Martin, D.
    LUPUS, 2018, 27 (02) : 312 - 318
  • [37] Clinical characteristics and complications of kidney transplantation among an Egyptian pediatric cohort
    Korkor, Mai S.
    El-desoky, Tarek
    Mosaad, Youssef M.
    Salah, Doaa M.
    Hammad, Ayman
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (05): : E117 - E125
  • [38] Clinicopathological Characteristics and Outcomes of Chinese Patients with Scanty Immune Deposits Lupus Nephritis: A Large Cohort Study from a Single Center
    Li, Qiuyu
    Song, Di
    Wang, Fengmei
    Tan, Ying
    Yu, Feng
    Zhao, Minghui
    SCIENTIFIC WORLD JOURNAL, 2014,
  • [39] The Impact of Serum Anti-neutrophil Cytoplasmic Antibody on Clinical Characteristics and Outcomes in Pediatric-Onset Systemic Lupus Erythematosus Patients
    Gau, Chun-Chun
    Tseng, Min-Hua
    Wu, Chao-Yi
    Yang, Huang-Yu
    Huang, Jing-Long
    FRONTIERS IN MEDICINE, 2021, 8
  • [40] Prevalence of lupus nephritis and the use of serology in a central South African chronic kidney disease patient cohort
    Lange, Kirsten
    Bisiwe, Feziwe
    Kloppers, Jean
    van Rensburg, Walter Janse
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2023, 113 (04): : 1132 - 1133